Zach began writing for CNET in November, 2021 after writing for a broadcast news station in his hometown, Cincinnati, for five years. You can usually find him reading and drinking coffee or watching a ...

TikTok has officially declared it grind season. A viral trend known as The Great Lock In is sweeping the platform, encouraging people to dedicate the final months of 2025 to extreme focus and ...

They look, move and even smell like the kind of furry Everglades marsh rabbit a Burmese python would love to eat. But these bunnies are robots meant to lure the giant invasive snakes out of their ...

Marni Rose McFall is a Newsweek reporter based in London, U.K. Her focus is on internet trends, U.S. politics and popular culture. She has covered fashion, culture, art and music extensively. Marni ...

BTS member Jungkook has vowed strong action against repeated invasions of his privacy after a woman was arrested for breaking into his home. During a Weverse live-stream held on Monday to mark his ...

As the latest star-studded class enters the Basketball Hall of Fame this weekend, we can't help but look to the future and wonder which active players might receive the honor after they retire.

The wardrobe staple gets a chic refresh in patent leather and plush suede. From Prada to Bottega, see our edit of the best bucket bags to shop for autumn 2025.

Sivakarthikeyan's soaring popularity in Tamil cinema is reflected in his escalating salary. His upcoming film 'Madharaasi' has generated significant buzz, particularly regarding his remuneration.

Starring Caleb Landry Jones (“Harvest”), two-time Academy Award winner Christoph Waltz (“Django Unchained,” “Inglourious Basterds”) and Zoë Bleu (“Gonzo Girl”), the film is set for a wide theatrical ...

Households are being urged to lock in a new mortgage deal as soon as possible, after Barclays announced it's upping rates. The mortgage lender is increasing rates across a number of its best buy deals ...

A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly’s blockbuster GLP-1 drug to treat obesity. When the major pharmacy benefit manager ...